Key result
Altered micro-RNA expression plays a crucial role in the development of diabetic cardiomyopathy.
Why the study?
The pathogenesis of diabetic cardiomyopathy was not well understood in the past due to its complexity, and the role of miRNAs in DCM is emerging.
This review outlines the multifactorial pathogenesis of diabetic cardiomyopathy, emphasizing the emerging regulatory role of micro-RNAs.
Answers are grounded in this paper and cite their sources.
Micro-RNA profiling should not yet guide diabetic cardiomyopathy care; leaves open biomarker and therapeutic roles pending prospective validation.
Diabetic cardiomyopathy is characterized as abnormal function and structure of myocardium associated with diabetes irrespective of other cardiac risk factors like hypertension or coronary artery disease (CAD). The pathogenesis of DCM was not well understood in the past due to its complexity but it has been discovered recently. Various factors are found to be associated with the onset of DCM including impaired calcium handling, remodeling of extracellular matrix (ECM), increased oxidative stress, altered metabolism, mitochondrial dysfunction, and endothelial dysfunction. Micro-RNAs (miRNAs) are also found to be of great importance in the pathogenesis of DCM. Different miRNAs like miR-126, miR-24, miR-1, miR-155, miR-499, and miR-199a are found to be associated with different types of heart diseases like CAD and myocardial infarction. Studies have shown that the miRNA plays a crucial role in the development of DCM and it was found that the expression levels of different miRNAs differ in patients as compared to healthy individuals. This review focuses on the pathogenesis of DCM and various factors involved in the onset of diabetic car-diomyopathy. Moreover, the probable role of miRNA in the pathogenesis of DCM is also discussed.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2021) conducted a review in Diabetic cardiomyopathy. Micro-RNAs (miRNAs) was evaluated. Micro-RNAs play a crucial role in the development of diabetic cardiomyopathy, with expression levels differing in patients compared to healthy individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: